Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Statin Intake on Cellular Readouts
NCT06469450Phase 1Recruiting
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atorvastatin in hypercholesterolemia. Primary endpoint: Lipid trafficking score LT-Mo at 5 weeks. Started Apr 2024; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06469450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06469450.